189 related articles for article (PubMed ID: 23180038)
1. Antineutrophil cytoplasmic autoantibody-associated vasculitis in Chinese patients.
Xu PC; Chen M; Zhao MH
Clin Exp Nephrol; 2013 Oct; 17(5):705-707. PubMed ID: 23180038
[TBL] [Abstract][Full Text] [Related]
2. ANCA-associated vasculitis: report from Korea.
Kim HW; Song YW
Clin Exp Nephrol; 2013 Oct; 17(5):708-711. PubMed ID: 23292177
[TBL] [Abstract][Full Text] [Related]
3. PR3-ANCA: a potential biomarker of disease activity for propylthiouracil-induced ANCA-associated vasculitis.
Hasegawa A; Fujimoto A; Yuki D; Hayashi R; Aizawa A; Ito T; Abe R
Eur J Dermatol; 2018 Aug; 28(4):530-531. PubMed ID: 29888703
[No Abstract] [Full Text] [Related]
4. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
Wang C; Gou SJ; Xu PC; Zhao MH; Chen M
Arthritis Res Ther; 2013; 15(6):R196. PubMed ID: 24252385
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
7. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
8. Distinct HLA and non-HLA associations in different subtypes of ANCA-associated vasculitides in North India.
Singh J; Sharma A; Rani L; Kaur N; Anand S; Saikia B; Jha S; Nada R; Minz RW
Int J Rheum Dis; 2020 Jul; 23(7):958-965. PubMed ID: 32297471
[TBL] [Abstract][Full Text] [Related]
9. Presence of dual anti-MPO and anti-PR3 antibodies in Systemic Lupus Erythematosus/ANCA-Associated Vasculitis.
Fernando SL; Boyle T
J Clin Pathol; 2020 Oct; 73(10):687-688. PubMed ID: 32513843
[No Abstract] [Full Text] [Related]
10. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ
Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777
[TBL] [Abstract][Full Text] [Related]
11. VISUAL VIGNETTE.
Sandhu SS; Dhindsa SS; Kuhadiya ND; Dandona P
Endocr Pract; 2018 Nov; 24(11):1019. PubMed ID: 30106633
[No Abstract] [Full Text] [Related]
12. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.
Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X
Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Bornstein G; Ben-Zvi I; Furie N; Grossman C
Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
[TBL] [Abstract][Full Text] [Related]
14. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
Holle JU
Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
[No Abstract] [Full Text] [Related]
15. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
Galante JR; Daruwalla CP; Roberts ISD; Haynes R; Storey BC; Bottomley MJ
BMC Nephrol; 2020 Jul; 21(1):295. PubMed ID: 32703233
[TBL] [Abstract][Full Text] [Related]
16. ANCA testing: the current stage and perspectives.
Csernok E
Clin Exp Nephrol; 2013 Oct; 17(5):615-618. PubMed ID: 23180043
[TBL] [Abstract][Full Text] [Related]
17. L34. Neutrophils in ANCA-associated vasculitis: still under investigation.
Witko-Sarsat V
Presse Med; 2013 Apr; 42(4 Pt 2):595-7. PubMed ID: 23481359
[No Abstract] [Full Text] [Related]
18. ANCA-Associated Vasculitis: Core Curriculum 2020.
Geetha D; Jefferson JA
Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
Csernok E; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
